Results 11 to 20 of about 270,005 (271)

Lipolysis generates platelet dysfunction after in vivo heparin administration [PDF]

, 2002
Heparin, when administered to patients undergoing operations using cardiopulmonary bypass, induces plasma changes that gradually impair platelet macroaggregation, but heparinization of whole blood in vitro does not have this effect.
Day, S., Caslake, M.J., Wheatley, D.J., Day, SP, Caslake, MJ, Chaudhry, MA, Chaudhry, M.A., Muriithi, E.W., Wheatley, DJ, Muriithi, EW, Belcher, P.R., Belcher, PR   +11 more
core   +8 more sources

Circulating small extracellular vesicle-encapsulated SEMA5A-IT1 attenuates myocardial ischemia–reperfusion injury after cardiac surgery with cardiopulmonary bypass

Cellular & Molecular Biology Letters, 2022
Cardiomyocyte injury is a common complication during cardiac surgery with cardiopulmonary bypass (CPB). Studies have shown that circulating small extracellular vesicles (sEVs) are involved in the pathological process of cardiovascular diseases via ...
Ting Wu, Guoning Shi, Zhenhua Ji, Shu Wang, Lizhu Geng, Zhigang Guo   +5 more
doaj   +1 more source

Mortality prediction in pediatric postcardiotomy veno-arterial extracorporeal membrane oxygenation: A comparison of scoring systems

Frontiers in Medicine, 2022
BackgroundPediatric postcardiotomy veno-arterial extracorporeal membrane oxygenation (VA-ECMO) patients have high mortality and morbidity. There are currently three scoring systems available to predict mortality: the Pediatric Extracorporeal Membrane ...
Yu Jin, Peng Gao, Peiyao Zhang, Liting Bai, Yixuan Li, Wenting Wang, Zhengyi Feng, Xu Wang, Jinping Liu   +8 more
doaj   +1 more source

Impact of angiotensin converting enzyme inhibition on post- coronary artery bypass interleukin 6 release [PDF]

, 2002
Background: Angiotensin 1 converting enzyme (ACE) inhibitors reduce morbidity and mortality after coronary artery bypass graft surgery (CABG). This benefit may result from an anti- inflammatory action.
Humphries, S.E., Rumley, A., Lowe, G.D., Montgomery, H.E., Sanders, J., Brull, D.J.   +5 more
core   +8 more sources

An Agreement Study Between Point-of-Care and Laboratory Activated Partial Thromboplastin Time for Anticoagulation Monitoring During Extracorporeal Membrane Oxygenation

Frontiers in Medicine, 2022
BackgroundLaboratory activated partial thromboplastin time (LAB-aPTT) is a widely used laboratory assay for monitoring unfractionated heparin (UFH) therapy during extracorporeal membrane oxygenation (ECMO).
Yuan Teng, Shujie Yan, Gang Liu, Song Lou, Yang Zhang, Bingyang Ji   +5 more
doaj   +1 more source

AdipoRon Inhibits Neuroinflammation Induced by Deep Hypothermic Circulatory Arrest Involving the AMPK/NF-κB Pathway in Rats

Pharmaceutics, 2022
Deep hypothermic circulatory arrest (DHCA) can induce systemic inflammatory response syndrome, including neuroinflammation. Finding suitable compounds is necessary for attenuating neuroinflammation and avoiding cerebral complications following DHCA.
Weidong Yan, Sizhe Gao, Qiaoni Zhang, Jiachen Qi, Gang Liu, Yuan Teng, Jian Wang, Shujie Yan, Bingyang Ji   +8 more
doaj   +1 more source

Evaluation of Acute Kidney Injury in Postcardiotomy Cardiogenic Shock Patients Supported by Extracorporeal Membrane Oxygenation

Reviews in Cardiovascular Medicine, 2023
Background: This study sought to evaluate the incidence of acute kidney injury (AKI) defined by the Kidney Disease: Improving Global Outcomes (KDIGO) group in patients supported by veno-arterial extracorporeal membrane oxygenation (VA ECMO) after post ...
Jiachen Qi, Weidong Yan, Gang Liu, Yuan Teng, Sizhe Gao, Shujie Yan, Jian Wang, Boyi Zhou, Bingyang Ji   +8 more
doaj   +1 more source

Interventional bronchoscopy for benign tracheobronchial diseases under cardiopulmonary bypass support: case reports and literature review [PDF]

, 2008
The use of cardiopulmonary bypass as an adjunct to airway surgery for non-malignant diseases in adults is not well established in the UK. We are reporting two cases which demonstrate the additional benefits of using cardiopulmonary bypass during ...
Barnard, Sion, Stephen Clark, Wigfield Christopher H, Clark Stephen, Christopher H. Wigfield, Hussamuddin Adwan, Barnard Sion, Wigfield, Christopher, Adwan Hussamuddin, Sion Barnard, Adwan, Hussamuddin, Clark, Stephen   +11 more
core   +2 more sources

Anticoagulation in Cardiopulmonary Bypass [PDF]

Thrombosis and Haemostasis, 1977
Prolonging the activated clotting time (ACT) 2 to 3 times normal is said to provide a “safe” level of anticoagulation during cardiopulmonary bypass. To test this level of anticoagulation 9 monkeys were anticoagulated with heparin at the start of cardiopulmonary bypass so that ACT’s ranged from 201 sec to > 1000 sec (normal 91 sec).
C Thomas Klsker, John A Young, Donald B Doty, Barbara J Taylor   +3 more
openaire   +2 more sources

Perioperative Outcomes of Using Different Temperature Management Strategies on Pediatric Patients Undergoing Aortic Arch Surgery: A Single-Center, 8-Year Study

Frontiers in Pediatrics, 2018
Background: With the widespread application of regional low-flow perfusion (RLFP), development of surgical techniques, and shortened circulatory arrest time, deep hypothermia is indispensable for organ protection.
Yuanyuan Tong, Jinping Liu, Lihua Zou, Zhengyi Feng, Chun Zhou, Ruoning Lv, Yu Jin   +6 more
doaj   +1 more source